Publication | Closed Access

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

Treatment And PreventionHuman RetrovirusAntiviral TherapyNon-inferiority Sword-1Virological SuppressionPharmacotherapyChronic Viral InfectionAntiviral DrugHivMedicinePhase 3